Dekabank Deutsche Girozentrale / BMY
Dekabank Deutsche Girozentrale’s Bristol-Myers Squibb Co Position
Does Dekabank Deutsche Girozentrale own Bristol-Myers Squibb Co (BMY)? Yes — 3.78M shares worth $230M (+0.38% of its 13F portfolio) as of Q1 2026.
Position Value
$230M
Q1 2026
Shares
3.78M
% of Portfolio
+0.38%
Quarters Held
29
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 3.78M | $230M | +0.38% |
| Q4 2025 | 3.78M | $185M | +0.32% |
| Q3 2025 | 3.78M | $169M | +0.28% |
| Q2 2025 | 3.78M | $176M | +0.31% |
| Q1 2025 | 3.89M | $232M | +0.46% |
| Q4 2024 | 3.78M | $215M | +0.40% |
| Q3 2024 | 3.78M | $194M | +0.36% |
| Q2 2024 | 4.24M | $177M | +0.32% |
| Q1 2024 | 3.89M | $209M | +0.39% |
| Q4 2023 | 3.95M | $203M | +0.42% |
| Q3 2023 | 4.01M | $233M | +0.54% |
| Q2 2023 | 4.06M | $261M | +0.59% |
| Q1 2023 | 4.02M | $273M | +0.69% |
| Q4 2022 | 3.73M | $267M | +0.71% |
| Q3 2022 | 3.57M | $257M | +0.76% |
| Q2 2022 | 3.43M | $264M | +0.77% |
| Q1 2022 | 3.43M | $253M | +0.62% |
| Q4 2021 | 3.06M | $191M | +0.46% |
| Q3 2021 | 3.24M | $196M | +0.55% |
| Q2 2021 | 3.15M | $208M | +0.61% |
| Q1 2021 | 2.61M | $165M | +0.55% |
| Q3 2020 | 2.50M | $148M | +0.66% |
| Q2 2020 | 1.82M | $106M | +0.67% |
| Q1 2020 | 1.79M | $99M | +0.76% |
| Q4 2019 | 1.67M | $108M | +0.66% |
| Q3 2019 | 433.7K | $22M | +0.14% |
| Q2 2019 | 458.4K | $21M | +0.10% |
| Q1 2019 | 483.7K | $30M | +0.18% |
| Q4 2018 | 492.3K | $25M | +0.17% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dekabank Deutsche Girozentrale’s full portfolio or all institutional holders of BMY.